[Evaluation of the therapeutic effects of broncaspin in chronic bronchopneumopathies].

Abstract

A controlled single-blind clinical trial was made with Broncaspin, on original synthetic molecule obtained by condensing acetylsalicylic acid and guaiacol, in a comparison of its local and general tolerance, and antipyretic, antiexudative and balsamic properties with those of dimethylaminophenazone guaiacolglycolate, a well-known preparation, in two randomly composed groups of 15 patients with chronic obstructive bronchial and lung diseases, using 1,2 g Broncaspin suppositories and the commercial form of the other product twice a day for 14 consecutive days. Therapeutic assessment was based on the symptomatological, spirometric and blood gas data.

• Authors: G Gunella, C Galleri
• Journal: Minerva medica (Minerva Med) Vol. 72 Issue 7 Pg. 379-86 (Feb 28 1981) ISSN: 0026-4806 [Print] Italy
• Vernacular Title: Valutazione degli effetti terapeutici del "Broncaspin" nei broncopneumopatici cronici.
• PMID: 7017488 (Publication Type: Clinical Trial, Comparative Study, English Abstract, Journal Article, Randomized Controlled Trial)

Chemical References

• Adrenal Cortex Hormones
• Anti-Bacterial Agents
• Drug Combinations
• Aminopyrine
• Guaiacol
• Aspirin
• guacetisal

Topics

• Adrenal Cortex Hormones (therapeutic use)
• Aminopyrine (analogs & derivatives, therapeutic use)
• Anti-Bacterial Agents (therapeutic use)
• Aspirin (analogs & derivatives, therapeutic use)
• Bronchial Diseases (drug therapy)
• Clinical Trials as Topic
• Drug Combinations
• Drug Evaluation
• Guaiacol (analogs & derivatives, therapeutic use)
• Humans
• Lung Diseases, Obstructive (drug therapy)
• Respiration (drug effects)
• Spirometry